English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2287]
News [5258]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
Latest in EGFR-positive NSCLC with exon 20 insertion mutations
Prof Sanjay Popat, Prof Michael Thomas, Dr Marina Garassino, Dr Rosario Campelo...
Latest in EGFR-positive NSCLC with exon 20 insertion mutations ( Prof Sanjay Popat, Prof Michael Thomas, Dr Marina Garassino, Dr Rosario Campelo, Dr Enriqueta Felip )
9 Feb 2021
WCLC 2020 overview
Dr Luis Raez - Memorial Healthcare System, Hollywood, FL, USA
WCLC 2020 overview ( Dr Luis Raez - Memorial Healthcare System, Hollywood, FL, USA )
5 Feb 2021
Emergence of PARP inhibitors in prostate cancer
Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals...
Emergence of PARP inhibitors in prostate cancer ( Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals, London, UK )
5 Feb 2021
OncoAlert and ecancer weekly roundup for January 25 - 31, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for January 25 - 31, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
4 Feb 2021
Role of PARP inhibitors in treating advanced prostate cancer
Noam Shabani - Dana-Farber Cancer Institute, Boston, USA
Role of PARP inhibitors in treating advanced prostate cancer ( Noam Shabani - Dana-Farber Cancer Institute, Boston, USA )
3 Feb 2021
WCLC 2020: Updates from the CHRYSALIS trial and what it means for patients with...
Dr Joshua Bauml and Dr Joshua Sabari
WCLC 2020: Updates from the CHRYSALIS trial and what it means for patients with NSCLC ( Dr Joshua Bauml and Dr Joshua Sabari )
3 Feb 2021
New data from rare EGFR alterations in NSCLC from WCLC 2020
Prof Tony Mok - Chinese University of Hong Kong, Shatin, Hong Kong
New data from rare EGFR alterations in NSCLC from WCLC 2020 ( Prof Tony Mok - Chinese University of Hong Kong, Shatin, Hong Kong )
2 Feb 2021
A new way of thinking on the origin of breast cancer and how early breast...
Prof László Tabár - University of Uppsala, Uppsala, Sweden
A new way of thinking on the origin of breast cancer and how early breast cancer should be treated ( Prof László Tabár - University of Uppsala, Uppsala, Sweden )
29 Jan 2021
The history of breast cancer diagnosis
Prof László Tabár - University of Uppsala, Uppsala, Sweden
The history of breast cancer diagnosis ( Prof László Tabár - University of Uppsala, Uppsala, Sweden )
29 Jan 2021
Recent therapies for HER2 advanced breast cancer
Dr Sandra Swain - Georgetown University, Washington DC, USA
Recent therapies for HER2 advanced breast cancer ( Dr Sandra Swain - Georgetown University, Washington DC, USA )
29 Jan 2021
BRCA mutation in metastatic TNBC patients
Prof Nagi El Saghir - American University of Beirut, Beirut, Lebanon
BRCA mutation in metastatic TNBC patients ( Prof Nagi El Saghir - American University of Beirut, Beirut, Lebanon )
28 Jan 2021
The role of immune checkpoint inhibitors in NSCLC
Dr Maurice Pérol, Centre Léon Bérard, Lyon, France
The role of immune checkpoint inhibitors in NSCLC ( Dr Maurice Pérol, Centre Léon Bérard, Lyon, France )
27 Jan 2021
<1...5455565758...191>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top